Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Gen-Probe Medical Equipment Company Share Analysis

 

Publication Date July 2008
Publisher Global Markets Direct
Product Type Report
Pages 165
ISBN Number not applicable
Product Code GMD01705

Price

£335.00
approximately: $507 | €374

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Gen-Probe Medical Equipment Company Share Analysis

This report is an essential source for data, analysis and strategic insight into Gen-Probe. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

  • Revenues for the markets and sub-sectors Gen-Probe. operates in by country and region.
  • Detailed breakdowns of revenues and market share benchmarked against competitors.
  • Profiles of the pipeline of products that the company is developing.
  • Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
  • Provides summary analysis of key revenue lines and strategy.
  • Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
  • Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

  • A single source to fulfill all of your business and competitor intelligence needs
  • Research your competitors business structure, strategy and prospects.
  • Counter your competitors strengths and target their weaknesses.
  • Identify your competitors key revenue streams by market and geography.
  • Identify and assess potential corporate and investment opportunities
  • Support sales activities by understanding your customers businesses better.
  • Identify potential competitor products before they reach market.
  • Qualify prospective partners and suppliers.

Contents

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What is this report about?
    • 2.2 Definitions
      • 2.2.1 In Vitro Diagnostics
        • 2.2.1.1 Microbiology Test Reagents
        • 2.2.1.2 Blood Test Reagents
        • 2.2.1.3 Instruments
        • 2.2.1.4 Infectious Immunology Test Reagents
    • 3 Company Snapshot
      • 3.1 Key Information
      • 3.2 Company Overview
      • 3.3 Financial Performance
      • 3.4 Industry Outlook - In Vitro Diagnostics
      • 3.5 SWOT Snapshot
    • 4 Business Description
      • 4.1 Business Overview
      • 4.2 Clinical Diagnostics and Blood Screening products
        • 4.2.1 Overview
        • 4.2.2 Financials
        • 4.2.3 Market View
        • 4.2.4 Key Strategies
      • 4.3 Major Products and Services
        • 4.3.1 Overview
    • 5 History
    • 6 Business Strategy
      • 6.1 Mission Statement
      • 6.2 Strategy
      • 6.3 Corporate Social Responsibility
        • 6.3.1 Overview
    • 7 Value Chain Analysis
      • 7.1 Manufacturing
        • 7.1.1 In House Manufacturing
        • 7.1.2 Outsourcing
      • 7.2 Product Development
        • 7.2.1 Regulatory Approvals
        • 7.2.2 Clinical Trials
        • 7.2.3 Research and Development
      • 7.3 Sales and Marketing
        • 7.3.1 Partnerships and Alliances
        • 7.3.2 Licensing Agreements
    • 8 SWOT Analysis
      • 8.1 Overview
      • 8.2 Gen-Probe Incorporated Strengths
        • 8.2.1 Core technologies
        • 8.2.2 Constant financial growth
        • 8.2.3 Research and development activities
      • 8.3 Gen-Probe Incorporated Weaknesses
        • 8.3.1 High focus on North America
        • 8.3.2 Product recalls
        • 8.3.3 Single third party manufacturers
      • 8.4 Gen-Probe Incorporated Opportunities
        • 8.4.1 Wide range of FDA approved products
        • 8.4.2 Awards
      • 8.5 Gen-Probe Incorporated Threats
        • 8.5.1 Limited manufacturing facilities
        • 8.5.2 Use of biological and harmful materials
        • 8.5.3 Implementation problem of information technology systems
    • 9 Competitors
    • 10 Gen-Probe Incorporated Medical Equipment Market Share Analysis
      • 10.1 Gen-Probe Incorporated, Global, Market Share (2006)
      • 10.2 Gen-Probe Incorporated, APAC, Market Share (2006)
      • 10.3 Gen-Probe Incorporated, Europe, Market Share (2006)
      • 10.4 Gen-Probe Incorporated, MEA, Market Share (2006)
      • 10.5 Gen-Probe Incorporated, North America, Market Share (2006)
      • 10.6 Gen-Probe Incorporated, SCA, Market Share (2006)
    • 11 Revenue Analysis
      • 11.1 Revenue by Segment
      • 11.2 Revenue by Geography
    • 12 Financial and Operational Review
      • 12.1 Financial Statements
      • 12.2 Financial Ratios
    • 13 Share Holding Structure
    • 14 Key Employees
    • 15 Key Employee Biographies
    • 16 Company Statement
    • 17 Locations And Subsidiaries
      • 17.1 Head Office
    • 18 Financial Deals Landscape
      • 18.1 Gen-Probe Signs An Agreement With 3M Company
      • 18.2 Gen-Probe Signs An Agreement With 3M
      • 18.3 Gen-Probe Acquires Stake In Qualigen
      • 18.4 Gen-Probe Signs An Agreement With Alnylam Pharmaceuticals
      • 18.5 Gen-Probe Signs An Agreement With Molecular Profiling Institute
      • 18.6 Gen-Probe Signs An Agreement With Millipore
      • 18.7 bioMerieux Signs An Agreement With Gen-Probe
      • 18.8 bioMerieux Signs An Agreement With Gen-Probe
    • 19 Recent Developments
      • 19.1 Apr 28, 2008: Gen-Probe Declares Q1 2008 Results
      • 19.2 Apr 28, 2008: Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
      • 19.3 Apr 10, 2008: Gen-Probe To Declare Q1 2008 Results
      • 19.4 Feb 11, 2008: Gen-Probe Appoints President
      • 19.5 Feb 11, 2008: Gen-Probe Appoints COO
      • 19.6 Nov 19, 2007: Gen-Probe Appoints VP, Operations
      • 19.7 Oct 30, 2007: Gen-Probe Reports Q3 2007 Results
      • 19.8 Sep 20, 2007: Gen-Probe Elects New Board Member
      • 19.9 Aug 01, 2007: Gen-Probe Declares Q2 2007 Results
      • 19.10 May 01, 2007: Gen-Probe Declares Q1 2007 Results
      • 19.11 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
      • 19.12 Feb 13, 2007: Gen-Probe Declares Q4 2006 Results
      • 19.13 Feb 13, 2007: Gen-Probe COO To Join
      • 19.14 Feb 13, 2007: Gen-Probe Declares Q4 2007 Results
    • 20 Gen-Probe Incorporated Pipeline Products
      • 20.1 APTIMA HPV Assay
        • 20.1.1 Product Overview
        • 20.1.2 Product Description
        • 20.1.3 Product Status
        • 20.1.4 Product Milestone
      • 20.2 PROGENSA PCA3 Assay
        • 20.2.1 Product Overview
        • 20.2.2 Product Description
        • 20.2.3 Product Status
        • 20.2.4 Clinical Trials
        • 20.2.5 Product Milestone
      • 20.3 Panther System
        • 20.3.1 Product Overview
        • 20.3.2 Product Description
        • 20.3.3 Product Status
      • 20.4 PROCLEIX ULTRIO assay for hepatitis B virus
        • 20.4.1 Product Overview
        • 20.4.2 Product Description
        • 20.4.3 Product Status
        • 20.4.4 Product Milestone
      • 20.5 Methicillin-resistant Staphylococcus aureus nucleic acid test
        • 20.5.1 Product Overview
        • 20.5.2 Product Description
        • 20.5.3 Product Status
        • 20.5.4 Product Milestone
    • 21 Appendix
      • 21.1 Global Markets Direct Research Methodology
      • 21.2 Coverage
      • 21.3 Secondary Research
      • 21.4 Primary Research
      • 21.5 Models
      • 21.6 Forecasts
      • 21.7 Expert Panels
      • 21.8 Market Revenue Chapters
        • 21.8.1 Abbreviations
        • 21.8.2 Currency Conversions
      • 21.9 Contact Us
      • 21.10 Disclaimer
    • 1.1 List of Tables
      • Table 1: Gen-Probe Incorporated,Key Facts, 2006
      • Table 2: Gen-Probe Incorporated, SWOT Analysis, 2006
      • Table 3: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Revenue ($ mn) and Market Share (%), 2006
      • Table 4: Gen-Probe Incorporated, In Vitro Diagnostics, APAC, Revenue ($ mn) and Market Share (%), 2006
      • Table 5: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Revenue ($ mn) and Market Share (%), 2006
      • Table 6: Gen-Probe Incorporated, In Vitro Diagnostics, China, Revenue ($ mn) and Market Share (%), 2006
      • Table 7: Gen-Probe Incorporated, In Vitro Diagnostics, India, Revenue ($ mn) and Market Share (%), 2006
      • Table 8: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Revenue ($ mn) and Market Share (%), 2006
      • Table 9: Gen-Probe Incorporated, In Vitro Diagnostics, New Zealand, Revenue ($ mn) and Market Share (%), 2006
      • Table 10: Gen-Probe Incorporated, In Vitro Diagnostics, Republic of Korea, Revenue ($ mn) and Market Share (%), 2006
      • Table 11: Gen-Probe Incorporated, In Vitro Diagnostics, Taiwan, Revenue ($ mn) and Market Share (%), 2006
      • Table 12: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Revenue ($ mn) and Market Share (%), 2006
      • Table 13: Gen-Probe Incorporated, In Vitro Diagnostics, Austria, Revenue ($ mn) and Market Share (%), 2006
      • Table 14: Gen-Probe Incorporated, In Vitro Diagnostics, Belgium, Revenue ($ mn) and Market Share (%), 2006
      • Table 15: Gen-Probe Incorporated, In Vitro Diagnostics, Czech Republic, Revenue ($ mn) and Market Share (%), 2006
      • Table 16: Gen-Probe Incorporated, In Vitro Diagnostics, Finland, Revenue ($ mn) and Market Share (%), 2006
      • Table 17: Gen-Probe Incorporated, In Vitro Diagnostics, France, Revenue ($ mn) and Market Share (%), 2006
      • Table 18: Gen-Probe Incorporated, Diabetic Care Devices, Germany, Revenue ($ mn) and Market Share (%), 2006
      • Table 19: Gen-Probe Incorporated, In Vitro Diagnostics, Greece, Revenue ($ mn) and Market Share (%), 2006
      • Table 20: Gen-Probe Incorporated, In Vitro Diagnostics, Hungary, Revenue ($ mn) and Market Share (%), 2006
      • Table 21: Gen-Probe Incorporated, In Vitro Diagnostics, Ireland, Revenue ($ mn) and Market Share (%), 2006
      • Table 22: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Revenue ($ mn) and Market Share (%), 2006
      • Table 23: Gen-Probe Incorporated, In Vitro Diagnostics, Netherlands, Revenue ($ mn) and Market Share (%), 2006
      • Table 24: Gen-Probe Incorporated, In Vitro Diagnostics, Norway, Revenue ($ mn) and Market Share (%), 2006
      • Table 25: Gen-Probe Incorporated, In Vitro Diagnostics, Poland, Revenue ($ mn) and Market Share (%), 2006
      • Table 26: Gen-Probe Incorporated, In Vitro Diagnostics, Portugal, Revenue ($ mn) and Market Share (%), 2006
      • Table 27: Gen-Probe Incorporated, In Vitro Diagnostics, Russian Federation, Revenue ($ mn) and Market Share (%), 2006
      • Table 28: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Revenue ($ mn) and Market Share (%), 2006
      • Table 29: Gen-Probe Incorporated, In Vitro Diagnostics, Sweden, Revenue ($ mn) and Market Share (%), 2006
      • Table 30: Gen-Probe Incorporated, In Vitro Diagnostics, Switzerland, Revenue ($ mn) and Market Share (%), 2006
      • Table 31: Gen-Probe Incorporated, In Vitro Diagnostics, Turkey, Revenue ($ mn) and Market Share (%), 2006
      • Table 32: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Revenue ($ mn) and Market Share (%), 2006
      • Table 33: Gen-Probe Incorporated, In Vitro Diagnostics, MEA, Revenue ($ mn) and Market Share (%), 2006
      • Table 34: Gen-Probe Incorporated, In Vitro Diagnostics, Egypt, Revenue ($ mn) and Market Share (%), 2006
      • Table 35: Gen-Probe Incorporated, In Vitro Diagnostics, Israel, Revenue ($ mn) and Market Share (%), 2006
      • Table 36: Gen-Probe Incorporated, In Vitro Diagnostics, South Africa, Revenue ($ mn) and Market Share (%), 2006
      • Table 37: Gen-Probe Incorporated, In Vitro Diagnostics, UAE, Revenue ($ mn) and Market Share (%), 2006
      • Table 38: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Revenue ($ mn) and Market Share (%), 2006
      • Table 39: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Revenue ($ mn) and Market Share (%), 2006
      • Table 40: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Revenue ($ mn) and Market Share (%), 2006
      • Table 41: Gen-Probe Incorporated, In Vitro Diagnostics, SCA, Revenue ($ mn) and Market Share (%), 2006
      • Table 42: Gen-Probe Incorporated, In Vitro Diagnostics, Argentina, Revenue ($ mn) and Market Share (%), 2006
      • Table 43: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Revenue ($ mn) and Market Share (%), 2006
      • Table 44: Gen-Probe Incorporated, In Vitro Diagnostics, Chile, Revenue ($ mn) and Market Share (%), 2006
      • Table 45: Gen-Probe Incorporated, In Vitro Diagnostics, Mexico, Revenue ($ mn) and Market Share (%), 2006
      • Table 46: Gen-Probe Incorporated, Revenue by Segment, USD Thousand, 2002-2006
      • Table 47: Gen-Probe Incorporated, Revenue by Geography, USD Thousand, 2002-2006
      • Table 48: Gen-Probe Incorporated, Financial Statements, USD Thousand, 2002-2006
      • Table 49: Gen-Probe Incorporated, Financial Ratios, USD Thousand, 2002-2006
      • Table 50: Gen-Probe Incorporated, Share Holding Structure
      • Table 51: Gen-Probe Incorporated,Key Employees, 2006
      • Table 52: Abbreviations used in the Market Revenue Chapters
      • Table 53: Currency Conversion used in the Market Revenue Chapters
    • 1.2 List of Figures
      • Figure 1: Gen-Probe Incorporated, Value Chain Analysis
      • Figure 2: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Category Revenue Share (%), 2006
      • Figure 3: Gen-Probe Incorporated, In Vitro Diagnostics, Global, Share of Market (%), 2006
      • Figure 4: Gen-Probe Incorporated, In Vitro Diagnostics, APAC, Category Revenue Share (%), 2006
      • Figure 5: Gen-Probe Incorporated, In Vitro Diagnostics, APAC, Share of Market (%), 2006
      • Figure 6: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Category Revenue Share (%), 2006
      • Figure 7: Gen-Probe Incorporated, In Vitro Diagnostics, Australia, Share of Market (%), 2006
      • Figure 8: Gen-Probe Incorporated, In Vitro Diagnostics, China, Category Revenue Share (%), 2006
      • Figure 9: Gen-Probe Incorporated, In Vitro Diagnostics, China, Share of Market (%), 2006
      • Figure 10: Gen-Probe Incorporated, In Vitro Diagnostics, India, Category Revenue Share (%), 2006
      • Figure 11: Gen-Probe Incorporated, In Vitro Diagnostics, India, Share of Market (%), 2006
      • Figure 12: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Category Revenue Share (%), 2006
      • Figure 13: Gen-Probe Incorporated, In Vitro Diagnostics, Japan, Share of Market (%), 2006
      • Figure 14: Gen-Probe Incorporated, In Vitro Diagnostics, New Zealand, Category Revenue Share (%), 2006
      • Figure 15: Gen-Probe Incorporated, In Vitro Diagnostics, New Zealand, Share of Market (%), 2006
      • Figure 16: Gen-Probe Incorporated, In Vitro Diagnostics, Republic of Korea, Category Revenue Share (%), 2006
      • Figure 17: Gen-Probe Incorporated, In Vitro Diagnostics, Republic of Korea, Share of Market (%), 2006
      • Figure 18: Gen-Probe Incorporated, In Vitro Diagnostics, Taiwan, Category Revenue Share (%), 2006
      • Figure 19: Gen-Probe Incorporated, In Vitro Diagnostics, Taiwan, Share of Market (%), 2006
      • Figure 20: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Category Revenue Share (%), 2006
      • Figure 21: Gen-Probe Incorporated, In Vitro Diagnostics, Europe, Share of Market (%), 2006
      • Figure 22: Gen-Probe Incorporated, In Vitro Diagnostics, Austria, Category Revenue Share (%), 2006
      • Figure 23: Gen-Probe Incorporated, In Vitro Diagnostics, Austria, Share of Market (%), 2006
      • Figure 24: Gen-Probe Incorporated, In Vitro Diagnostics, Belgium, Category Revenue Share (%), 2006
      • Figure 25: Gen-Probe Incorporated, In Vitro Diagnostics, Belgium, Share of Market (%), 2006
      • Figure 26: Gen-Probe Incorporated, In Vitro Diagnostics, Czech Republic, Category Revenue Share (%), 2006
      • Figure 27: Gen-Probe Incorporated, In Vitro Diagnostics, Czech Republic, Share of Market (%), 2006
      • Figure 28: Gen-Probe Incorporated, In Vitro Diagnostics, Finland, Category Revenue Share (%), 2006
      • Figure 29: Gen-Probe Incorporated, In Vitro Diagnostics, Finland, Share of Market (%), 2006
      • Figure 30: Gen-Probe Incorporated, In Vitro Diagnostics, France, Category Revenue Share (%), 2006
      • Figure 31: Gen-Probe Incorporated, In Vitro Diagnostics, France, Share of Market (%), 2006
      • Figure 32: Gen-Probe Incorporated, In Vitro Diagnostics, Germany, Category Revenue Share (%), 2006
      • Figure 33: Gen-Probe Incorporated, In Vitro Diagnostics, Germany, Share of Market (%), 2006
      • Figure 34: Gen-Probe Incorporated, In Vitro Diagnostics, Greece, Category Revenue Share (%), 2006
      • Figure 35: Gen-Probe Incorporated, In Vitro Diagnostics, Greece, Share of Market (%), 2006
      • Figure 36: Gen-Probe Incorporated, In Vitro Diagnostics, Hungary, Category Revenue Share (%), 2006
      • Figure 37: Gen-Probe Incorporated, In Vitro Diagnostics, Hungary, Share of Market (%), 2006
      • Figure 38: Gen-Probe Incorporated, In Vitro Diagnostics, Ireland, Category Revenue Share (%), 2006
      • Figure 39: Gen-Probe Incorporated, In Vitro Diagnostics, Ireland, Share of Market (%), 2006
      • Figure 40: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Category Revenue Share (%), 2006
      • Figure 41: Gen-Probe Incorporated, In Vitro Diagnostics, Italy, Share of Market (%), 2006
      • Figure 42: Gen-Probe Incorporated, In Vitro Diagnostics, Netherlands, Category Revenue Share (%), 2006
      • Figure 43: Gen-Probe Incorporated, In Vitro Diagnostics, Netherlands, Share of Market (%), 2006
      • Figure 44: Gen-Probe Incorporated, In Vitro Diagnostics, Norway, Category Revenue Share (%), 2006
      • Figure 45: Gen-Probe Incorporated, In Vitro Diagnostics, Norway, Share of Market (%), 2006
      • Figure 46: Gen-Probe Incorporated, In Vitro Diagnostics, Poland, Category Revenue Share (%), 2006
      • Figure 47: Gen-Probe Incorporated, In Vitro Diagnostics, Poland, Share of Market (%), 2006
      • Figure 48: Gen-Probe Incorporated, In Vitro Diagnostics, Portugal, Category Revenue Share (%), 2006
      • Figure 49: Gen-Probe Incorporated, In Vitro Diagnostics, Portugal, Share of Market (%), 2006
      • Figure 50: Gen-Probe Incorporated, In Vitro Diagnostics, Russian Federation, Category Revenue Share (%), 2006
      • Figure 51: Gen-Probe Incorporated, In Vitro Diagnostics, Russian Federation, Share of Market (%), 2006
      • Figure 52: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Category Revenue Share (%), 2006
      • Figure 53: Gen-Probe Incorporated, In Vitro Diagnostics, Spain, Share of Market (%), 2006
      • Figure 54: Gen-Probe Incorporated, In Vitro Diagnostics, Sweden, Category Revenue Share (%), 2006
      • Figure 55: Gen-Probe Incorporated, In Vitro Diagnostics, Sweden, Share of Market (%), 2006
      • Figure 56: Gen-Probe Incorporated, In Vitro Diagnostics, Switzerland, Category Revenue Share (%), 2006
      • Figure 57: Gen-Probe Incorporated, In Vitro Diagnostics, Switzerland, Share of Market (%), 2006
      • Figure 58: Gen-Probe Incorporated, In Vitro Diagnostics, Turkey, Category Revenue Share (%), 2006
      • Figure 59: Gen-Probe Incorporated, In Vitro Diagnostics, Turkey, Share of Market (%), 2006
      • Figure 60: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2006
      • Figure 61: Gen-Probe Incorporated, In Vitro Diagnostics, United Kingdom, Share of Market (%), 2006
      • Figure 62: Gen-Probe Incorporated, In Vitro Diagnostics, MEA, Category Revenue Share (%), 2006
      • Figure 63: Gen-Probe Incorporated, In Vitro Diagnostics, MEA, Share of Market (%), 2006
      • Figure 64: Gen-Probe Incorporated, In Vitro Diagnostics, Egypt, Category Revenue Share (%), 2006
      • Figure 65: Gen-Probe Incorporated, In Vitro Diagnostics, Egypt, Share of Market (%), 2006
      • Figure 66: Gen-Probe Incorporated, In Vitro Diagnostics, Israel, Category Revenue Share (%), 2006
      • Figure 67: Gen-Probe Incorporated, In Vitro Diagnostics, Israel, Share of Market (%), 2006
      • Figure 68: Gen-Probe Incorporated, In Vitro Diagnostics, South Africa, Category Revenue Share (%), 2006
      • Figure 69: Gen-Probe Incorporated, In Vitro Diagnostics, South Africa, Share of Market (%), 2006
      • Figure 70: Gen-Probe Incorporated, In Vitro Diagnostics, UAE, Category Revenue Share (%), 2006
      • Figure 71: Gen-Probe Incorporated, In Vitro Diagnostics, UAE, Share of Market (%), 2006
      • Figure 72: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Category Revenue Share (%), 2006
      • Figure 73: Gen-Probe Incorporated, In Vitro Diagnostics, North America, Share of Market (%), 2006
      • Figure 74: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Category Revenue Share (%), 2006
      • Figure 75: Gen-Probe Incorporated, In Vitro Diagnostics, Canada, Share of Market (%), 2006
      • Figure 76: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Category Revenue Share (%), 2006
      • Figure 77: Gen-Probe Incorporated, In Vitro Diagnostics, United States, Share of Market (%), 2006
      • Figure 78: Gen-Probe Incorporated, In Vitro Diagnostics, SCA, Category Revenue Share (%), 2006
      • Figure 79: Gen-Probe Incorporated, In Vitro Diagnostics, SCA, Share of Market (%), 2006
      • Figure 80: Gen-Probe Incorporated, In Vitro Diagnostics, Argentina, Category Revenue Share (%), 2006
      • Figure 81: Gen-Probe Incorporated, In Vitro Diagnostics, Argentina, Share of Market (%), 2006
      • Figure 82: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2006
      • Figure 83: Gen-Probe Incorporated, In Vitro Diagnostics, Brazil, Share of Market (%), 2006
      • Figure 84: Gen-Probe Incorporated, In Vitro Diagnostics, Chile, Revenue ($ mn) and Market Share (%), 2006
      • Figure 85: Gen-Probe Incorporated, In Vitro Diagnostics, Chile, Share of Market (%), 2006
      • Figure 86: Gen-Probe Incorporated, In Vitro Diagnostics, Mexico, Category Revenue Share (%), 2006
      • Figure 87: Gen-Probe Incorporated, In Vitro Diagnostics, Mexico, Share of Market (%), 2006
      • Figure 88: Global Markets Direct Methodology
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis